Editorial: a clinical decision tool to identify patients who might benefit most from intensified dosing in the biological era—getting nearer? Authors' reply

Parambir S. Dulai*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)738-739
Number of pages2
JournalAlimentary Pharmacology and Therapeutics
Volume51
Issue number7
DOIs
StatePublished - Apr 1 2020

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology
  • Pharmacology (medical)

Cite this